Phase 4 Hemophilia A With Inhibitor Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis Network55 enrolled21 locationsNCT04647227
Recruiting
Phase 4
Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)
Hemophilia A With Inhibitor
Runhui WU110 enrolled1 locationNCT06864975
Recruiting
Phase 4
ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Hemophilia A With Inhibitor
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT05888870
Recruiting
Phase 4
Pharmacokinetic-guided Dosing of Emicizumab
AdultHemophilia A With InhibitorAdolescent+3 more
Kathelijn Fischer95 enrolled8 locationsNCT06320626